76 research outputs found
Observation of large-scale multi-agent based simulations
The computational cost of large-scale multi-agent based simulations (MABS)
can be extremely important, especially if simulations have to be monitored for
validation purposes. In this paper, two methods, based on self-observation and
statistical survey theory, are introduced in order to optimize the computation
of observations in MABS. An empirical comparison of the computational cost of
these methods is performed on a toy problem
Augmented Reality in Astrophysics
Augmented Reality consists of merging live images with virtual layers of
information. The rapid growth in the popularity of smartphones and tablets over
recent years has provided a large base of potential users of Augmented Reality
technology, and virtual layers of information can now be attached to a wide
variety of physical objects. In this article, we explore the potential of
Augmented Reality for astrophysical research with two distinct experiments: (1)
Augmented Posters and (2) Augmented Articles. We demonstrate that the emerging
technology of Augmented Reality can already be used and implemented without
expert knowledge using currently available apps. Our experiments highlight the
potential of Augmented Reality to improve the communication of scientific
results in the field of astrophysics. We also present feedback gathered from
the Australian astrophysics community that reveals evidence of some interest in
this technology by astronomers who experimented with Augmented Posters. In
addition, we discuss possible future trends for Augmented Reality applications
in astrophysics, and explore the current limitations associated with the
technology. This Augmented Article, the first of its kind, is designed to allow
the reader to directly experiment with this technology.Comment: 15 pages, 11 figures. Accepted for publication in Ap&SS. The final
publication will be available at link.springer.co
Lattice Study of the Decay B^0-bar -> rho^+ l^- nu_l-bar: Model-Independent Determination of |V_{ub}|
We present results of a lattice computation of the vector and axial-vector
current matrix elements relevant for the semileptonic decay B^0-bar -> rho^+
l^- nu_l-bar. The computations are performed in the quenched approximation of
lattice QCD on a 24^3 x 48 lattice at beta = 6.2, using an O(a) improved
fermionic action. Our principal result is for the differential decay rate,
dGamma/dq^2, for the decay B^0-bar -> rho^+ l^- nu_l-bar in a region beyond the
charm threshold, allowing a model-independent extraction of |V_{ub}| from
experimental measurements. Heavy quark symmetry relations between radiative and
semileptonic decays of B-bar mesons into light vector mesons are also
discussed.Comment: 22 pages LaTeX-209 (dependent on settings in a4.sty), 23 PostScript
figures included with epsf.sty. Complete PostScript file including figures
available at http://wwwhep.phys.soton.ac.uk/hepwww/papers/shep9518
Astroparticle Physics with a Customized Low-Background Broad Energy Germanium Detector
The MAJORANA Collaboration is building the MAJORANA DEMONSTRATOR, a 60 kg
array of high purity germanium detectors housed in an ultra-low background
shield at the Sanford Underground Laboratory in Lead, SD. The MAJORANA
DEMONSTRATOR will search for neutrinoless double-beta decay of 76Ge while
demonstrating the feasibility of a tonne-scale experiment. It may also carry
out a dark matter search in the 1-10 GeV/c^2 mass range. We have found that
customized Broad Energy Germanium (BEGe) detectors produced by Canberra have
several desirable features for a neutrinoless double-beta decay experiment,
including low electronic noise, excellent pulse shape analysis capabilities,
and simple fabrication. We have deployed a customized BEGe, the MAJORANA
Low-Background BEGe at Kimballton (MALBEK), in a low-background cryostat and
shield at the Kimballton Underground Research Facility in Virginia. This paper
will focus on the detector characteristics and measurements that can be
performed with such a radiation detector in a low-background environment.Comment: Submitted to NIMA Proceedings, SORMA XII. 9 pages, 4 figure
Energy Flow in the Hadronic Final State of Diffractive and Non-Diffractive Deep-Inelastic Scattering at HERA
An investigation of the hadronic final state in diffractive and
non--diffractive deep--inelastic electron--proton scattering at HERA is
presented, where diffractive data are selected experimentally by demanding a
large gap in pseudo --rapidity around the proton remnant direction. The
transverse energy flow in the hadronic final state is evaluated using a set of
estimators which quantify topological properties. Using available Monte Carlo
QCD calculations, it is demonstrated that the final state in diffractive DIS
exhibits the features expected if the interaction is interpreted as the
scattering of an electron off a current quark with associated effects of
perturbative QCD. A model in which deep--inelastic diffraction is taken to be
the exchange of a pomeron with partonic structure is found to reproduce the
measurements well. Models for deep--inelastic scattering, in which a
sizeable diffractive contribution is present because of non--perturbative
effects in the production of the hadronic final state, reproduce the general
tendencies of the data but in all give a worse description.Comment: 22 pages, latex, 6 Figures appended as uuencoded fil
A whole-blood transcriptome meta-analysis identifies gene expression signatures of cigarette smoking
Cigarette smoking is a leading modifiable cause of death worldwide. We hypothesized that cigarette smoking induces extensive transcriptomic changes that lead to target-organ damage and smoking-related diseases. We performed a metaanalysis of transcriptome-wide gene expression using whole blood-derived RNA from 10,233 participants of European ancestry in six cohorts (including 1421 current and 3955 former smokers) to identify associations between smoking and altered gene expression levels. At a false discovery rate (FDR) < 0.1, we identified 1270 differentially expressed genes in current vs. never smokers, and 39 genes in former vs. never smokers. Expression levels of 12 genes remained elevated up to 30 years after smoking cessation, suggesting that the molecular consequence of smoking may persist for decades. Gene ontology analysis revealed enrichment of smoking-related genes for activation of platelets and lymphocytes, immune response, and apoptosis. Many of the top smoking-related differentially expressed genes, including LRRN3 and GPR15, have DNA methylation loci in promoter regions that were recently reported to be hypomethylated among smokers. By linking differential gene expression with smoking-related disease phenotypes, we demonstrated that stroke and pulmonary function show enrichment for smoking-related gene expression signatures. Mediation analysis revealed the expression of several genes (e.g. ALAS2) to be putative mediators of the associations between smoking and inflammatory biomarkers (IL6 and C-re
A meta-analysis of gene expression signatures of blood pressure and hypertension
Genome-wide association studies (GWAS) have uncovered numerous genetic variants (SNPs) that are associated with blood pressure (BP). Genetic variants may lead to BP changes by acting on intermediate molecular phenotypes such as coded protein sequence or gene expression, which in turn affect BP variability. Therefore, characterizing genes whose expression is associated with BP may reveal cellular processes involved in BP regulation and uncover how transcripts mediate genetic and environmental effects on BP variability. A meta-analysis of results from six studies of global gene expression profiles of BP and hypertension in whole blood was performed in 7017 individuals who were not receiving antihypertensive drug treatment. We identified 34 genes that were differentially expressed in relation to BP (Bonferroni-corrected p<0.05). Among these genes, FOS and PTGS2 have been previously reported to be involved in BP-related processes; the others are novel. The top BP signature genes in aggregate explain 5%-9% of inter-individual variance in BP. Of note, rs3184504 in SH2B3, which was also reported in GWAS to be associated with BP, was found to be a trans regulator of the expression of 6 of the transcripts we found to be associated with BP (FOS, MYADM, PP1R15A, TAGAP, S100A10, and FGBP2). Gene set enrichment analysis suggested that the BP-related global gene expression changes include genes involved in inflammatory response and apoptosis pathways. Our study provides new insights into molecular mechanisms underlying BP regulation, and suggests novel transcriptomic markers for the treatment and prevention of hypertension
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
BACKGROUND Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. METHODS In this phase 3, double-blind, randomized, placebo-controlled trial, we used a 2-by-3 factorial design to test the effectiveness of three repurposed drugs - metformin, ivermectin, and fluvoxamine - in preventing serious SARS-CoV-2 infection in nonhospitalized adults who had been enrolled within 3 days after a confirmed diagnosis of infection and less than 7 days after the onset of symptoms. The patients were between the ages of 30 and 85 years, and all had either overweight or obesity. The primary composite end point was hypoxemia (≤93% oxygen saturation on home oximetry), emergency department visit, hospitalization, or death. All analyses used controls who had undergone concurrent randomization and were adjusted for SARSCoV-2 vaccination and receipt of other trial medications. RESULTS A total of 1431 patients underwent randomization; of these patients, 1323 were included in the primary analysis. The median age of the patients was 46 years; 56% were female (6% of whom were pregnant), and 52% had been vaccinated. The adjusted odds ratio for a primary event was 0.84 (95% confidence interval [CI], 0.66 to 1.09; P=0.19) with metformin, 1.05 (95% CI, 0.76 to 1.45; P=0.78) with ivermectin, and 0.94 (95% CI, 0.66 to 1.36; P=0.75) with fluvoxamine. In prespecified secondary analyses, the adjusted odds ratio for emergency department visit, hospitalization, or death was 0.58 (95% CI, 0.35 to 0.94) with metformin, 1.39 (95% CI, 0.72 to 2.69) with ivermectin, and 1.17 (95% CI, 0.57 to 2.40) with fluvoxamine. The adjusted odds ratio for hospitalization or death was 0.47 (95% CI, 0.20 to 1.11) with metformin, 0.73 (95% CI, 0.19 to 2.77) with ivermectin, and 1.11 (95% CI, 0.33 to 3.76) with fluvoxamine. CONCLUSIONS None of the three medications that were evaluated prevented the occurrence of hypoxemia, an emergency department visit, hospitalization, or death associated with Covid-19
The Majorana Demonstrator: Progress towards showing the feasibility of a tonne-scale 76Ge neutrinoless double-beta decay experiment
The Majorana Demonstrator will search for the neutrinoless double-beta decay (0vββ) of the 76Ge isotope with a mixed array of enriched and natural germanium detectors. The observation of this rare decay would indicate the neutrino is its own anti-particle, demonstrate that lepton number is not conserved, and provide information on the absolute mass-scale of the neutrino. The Demonstrator is being assembled at the 4850 foot level of the Sanford Underground Research Facility in Lead, South Dakota. The array will be contained in a low-background environment and surrounded by passive and active shielding. The goals for the Demonstrator are: demonstrating a background rate less than 3 t-1 y-1 in the 4 keV region of interest (ROI) surrounding the 2039 keV 76Ge endpoint energy; establishing the technology required to build a tonne-scale germanium based double-beta decay experiment; testing the recent claim of observation of 0vββ [1]; and performing a direct search for light WIMPs (3-10 GeV/c2)
Characteristics of signals originating near the lithium-diffused N+ contact of high purity germanium p-type point contact detectors
A study of signals originating near the lithium-diffused n+ contact of p-type point contact (PPC) high purity germanium detectors (HPGe) is presented. The transition region between the active germanium and the fully dead layer of the n+ contact is examined. Energy depositions in this transition region are shown to result in partial charge collection. This provides a mechanism for events with a well defined energy to contribute to the continuum of the energy spectrum at lower energies. A novel technique to quantify the contribution from this source of background is introduced. Experiments that operate germanium detectors with a very low energy threshold may benefit from the methods presented herein
- …